Architects of folding, editors of immunity: the strategic use of N-glycans in vaccine design.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Frontiers in Immunology

• Publication date

  2026-02-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fimmu.2026.1766701PMID 41789106PMCID PMC12957175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Manipulation of immunodominant variable epitopes of norovirus capsid protein elicited cross-blocking antibodies to different GII.4 variants despite the low potency of the polyclonal sera

  2025cited by this paper
• Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model

  2025cited by this paper
• Inferring Geographic Spread of Flaviviruses Through Analysis of Hypervariable Genomic Regions

  2025cited by this paper
• Deglycosylation significantly affects the activity, stability and appropriate folding of recombinant Aspergillus niger α-L-rhamnosidase expressed in Pichia pastoris.

  2025cited by this paper
• Protein-glycan engineering in vaccine design: merging immune mechanisms with biotechnological innovation.

  2025cited by this paper
• Design of universal Ebola virus vaccine candidates via immunofocusing

  2024cited by this paper
• Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization

  2024cited by this paper
• Income insecurity and social protection: Examining the impact of the COVID-19 pandemic across income groups

  2024cited by this paper
• CO-EXPRESSION OF HUMAN SIALYLTRANSFERASE IMPROVES N-GLYCOSYLATION IN Leishmania tarentolae AND OPTIMIZE THE PRODUCTION OF HUMANIZED THERAPEUTIC GLYCOPROTEIN IFN-BETA.

  2024cited by this paper
• Glycosylation: mechanisms, biological functions and clinical implications

  2024cited by this paper
• Impact of glycosylation on viral vaccines.

  2024cited by this paper
• Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants

  2023cited by this paper
• Deglycosylated RBD produced in Pichia pastoris as a low-cost sera COVID-19 diagnosis tool and a vaccine candidate.

  2023cited by this paper
• Dynamical changes of SARS‐CoV‐2 spike variants in the highly immunogenic regions impact the viral antibodies escaping

  2023cited by this paper
• Glycan masking in vaccine design: Targets, immunogens and applications

  2023cited by this paper
• A combinatorial DNA assembly approach to biosynthesis of N-linked glycans in E. coli

  2023cited by this paper
• Glycosylation of viral proteins: Implication in virus–host interaction and virulence

  2022cited by this paper
• Comparative analysis of plant transient expression vectors for targeted N-glycosylation

  2022cited by this paper
• Glycans in HIV-1 vaccine design - engaging the shield.

  2022cited by this paper
• Sweet systems: technologies for glycomic analysis and their integration into systems biology

  2021cited by this paper
• Development of vaccine formulations: past, present, and future

  2021cited by this paper
• HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules

  2021cited by this paper
• Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization

  2021cited by this paper
• Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice

  2021cited by this paper
• Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections

  2021cited by this paper
• N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in Plants

  2021cited by this paper
• Antibody and B cell responses to SARS-CoV-2 infection and vaccination

  2021cited by this paper
• 50 Years of structural immunology

  2021cited by this paper
• Effects of Pandemic Outbreak on Economies: Evidence From Business History Context

  2021cited by this paper
• Glycosylation as a tool for rational vaccine design

  2020cited by this paper
• Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris

  2020cited by this paper
• Differential effects of putative N-glycosylation sites in human Tau on Alzheimer’s disease-related neurodegeneration

  2020cited by this paper
• Impact of Vaccines; Health, Economic and Social Perspectives

  2020cited by this paper
• Site-specific glycan analysis of the SARS-CoV-2 spike

  2020cited by this paper
• The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries

  2020cited by this paper
• PolyBall: A new adsorbent for the efficient removal of endotoxin from biopharmaceuticals

  2019cited by this paper
• The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins.

  2019cited by this paper
• A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria

  2019cited by this paper
• Protein and Glycan Mimicry in HIV Vaccine Design

  2019cited by this paper
• Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes

  2018cited by this paper
• Impact of host cell line choice on glycan profile

  2018cited by this paper
• Glycan‐masking hemagglutinin antigens from stable CHO cell clones for H5N1 avian influenza vaccine development

  2018cited by this paper
• Glycan Masking Focuses Immune Responses to the HIV‐1 CD4‐Binding Site and Enhances Elicitation of VRC01‐Class Precursor Antibodies

  2018cited by this paper
• Simply put: Vaccination saves lives

  2017cited by this paper
• Role of glycosylation in nucleating protein folding and stability.

  2017cited by this paper
• A novel Meloidogyne graminicola effector, MgGPP, is secreted into host cells and undergoes glycosylation in concert with proteolysis to suppress plant defenses and promote parasitism

  2017cited by this paper
• Uropathogenic E. coli Exploit CEA to Promote Colonization of the Urogenital Tract Mucosa

  2016cited by this paper
• Biological roles of glycans

  2016cited by this paper
• Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.

  2016cited by this paper
• Protozoa lectins and their role in host-pathogen interactions.

  2016cited by this paper
• N-linked sugar-regulated protein folding and quality control in the ER.

  2015cited by this paper
• Article Commentary: Viral Resistance of MOGS-CDG Patients Implies a Broad-Spectrum Strategy against Acute Virus Infections

  2015cited by this paper
• Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds

  2015cited by this paper
• Engineering yeast for producing human glycoproteins: where are we now?

  2015cited by this paper
• Symbol Nomenclature for Graphical Representations of Glycans.

  2015cited by this paper
• Engineering the Pichia pastoris N-Glycosylation Pathway Using the GlycoSwitch Technology.

  2015cited by this paper
• Playing Hide and Seek: How Glycosylation of the Influenza Virus Hemagglutinin Can Modulate the Immune Response to Infection

  2014cited by this paper
• Glycan Masking of Hemagglutinin for Adenovirus Vector and Recombinant Protein Immunizations Elicits Broadly Neutralizing Antibodies against H5N1 Avian Influenza Viruses

  2014cited by this paper
• The contribution of vaccination to global health: past, present and future

  2014cited by this paper
• Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

  2014cited by this paper
• Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

  2014cited by this paper
• The activation and suppression of plant innate immunity by parasitic nematodes.

  2014cited by this paper
• Glycoprotein folding and quality-control mechanisms in protein-folding diseases

  2014cited by this paper
• Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins.

  2013cited by this paper
• HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1

  2013cited by this paper
• Recent advances in plant immunity: recognition, signaling, response, and evolution

  2013cited by this paper
• Mitogen-activated protein kinases in innate immunity

  2013cited by this paper
• The Role of N-Glycosylation in Folding, Trafficking, and Functionality of Lysosomal Protein CLN5

  2013cited by this paper
• Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains

  2013cited by this paper
• Broader Neutralizing Antibodies against H5N1 Viruses Using Prime-Boost Immunization of Hyperglycosylated Hemagglutinin DNA and Virus-Like Particles

  2012cited by this paper
• The impact of glycosylation on monoclonal antibody conformation and stability

  2011cited by this paper
• Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.

  2010cited by this paper
• N-glycan structures: recognition and processing in the ER.

  2010cited by this paper
• Vaccination greatly reduces disease, disability, death and inequity worldwide.

  2008cited by this paper
• Humanization of Yeast to Produce Complex Terminally Sialylated Glycoproteins

  2006cited by this paper
• Proteomic Analysis of Candida albicans Cell Walls Reveals Covalently Bound Carbohydrate-Active Enzymes and Adhesins

  2004cited by this paper
• The Haemophilus influenzae HMW1 adhesin is glycosylated in a process that requires HMW1C and phosphoglucomutase, an enzyme involved in lipooligosaccharide biosynthesis

  2003cited by this paper
• Viral immune evasion: a masterpiece of evolution

  2002cited by this paper
• Glycosylation and the immune system.

  2001cited by this paper
• Deglycosylation of the 45/47-Kilodalton Antigen Complex of Mycobacterium tuberculosis Decreases Its Capacity To Elicit In Vivo or In Vitro Cellular Immune Responses

  1999cited by this paper
• Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.

  1998cited by this paper
• Protection against hepatitis A by an inactivated vaccine.

  1994cited by this paper
• Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.

  1994cited by this paper
• High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells.

  1993cited by this paper

• No citing papers are available for this paper.